Safety, tolerability and pharmacokinetics/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first-in-human study and during experimental human endotoxaemia in healthy subjects

Geven, C.B.C.A.G.; Lier, D.P.T. van; Blet, A.; Peelen, R.V.; Elzen, Bas ten; Mebazaa, Alexandre; Kox, M.; Pickkers, P.

Fulltext:

194891.pdf

Embargo:

until further notice

Size:

1.460Mb

Format:

PDF

Description:

publisher's version

Publication year

2018

Author(s)

Kox, M.

Source

British Journal of Clinical Pharmacology, 84, 9, (2018), pp. 2129-2141

ISSN

0306-5251

DOI

https://doi.org/10.1111/bcp.13655

Publication type

Article / Letter to editor

Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/194891

Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.

Radboud Repository

Radboud Repository

Safety, tolerability and pharmacokinetics/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first-in-human study and during experimental human endotoxaemia in healthy subjects

Publication year

Author(s)

Source

ISSN

DOI

Publication type

Organization

Journal title

Volume

Issue

Page start

Page end

Subject

This item appears in the following Collection(s)